The text discusses whether diabetes is treated as a coronary artery disease risk equivalent in clinical practice, as recommended by guidelines.
Answers are grounded in this paper and cite their sources.
Real-world adherence to diabetes as CAD risk equivalent appears inconsistent; leaves open effects on outcomes and need for targeted studies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: